Mission BioCapital logo

Mission BioCapital

North America, Massachusetts, United States, Cambridge

Description

Mission BioCapital is a life science venture capital firm that invests in early-stage companies.

Investor Profile

Mission BioCapital has made 75 investments, with 16 in the past 12 months and 16% as lead.

Stage Focus

  • Series A (25%)
  • Series B (25%)
  • Series Unknown (24%)
  • Seed (11%)
  • Series C (7%)
  • Pre Seed (5%)
  • Series E (1%)
  • Series D (1%)

Country Focus

  • United States (96%)
  • Switzerland (3%)
  • Germany (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Life Science
  • Pharmaceutical
  • Genetics
  • Precision Medicine
  • Medical Device
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Mission BioCapital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 4
Amgen Ventures
North America, California, United States, San Francisco
Co-Investments: 4
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 6
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 7
Mission Bay Capital
North America, California, United States, San Francisco
Co-Investments: 7
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 6
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 5
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 4
AbbVie Biotech Ventures
North America, Illinois, United States, North Chicago
Co-Investments: 4
Inkef
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 4

Which angels does Mission BioCapital often collaborate with?

LW
North America, Washington, United States, Seattle
Shared Deals: 2
SH
North America, New York, United States, New York
Shared Deals: 1
AP
North America, California, United States, Los Angeles
Shared Deals: 1
MS
North America, California, United States, Santa Monica
Shared Deals: 1
VP
North America, New York, United States, New York
Shared Deals: 1
Stephen Thompson
Oceania, Victoria, Australia, Melbourne
Shared Deals: 1
JR
North America, California, United States, San Francisco
Shared Deals: 1
AI
Europe, Cyprus
Shared Deals: 1
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by Mission BioCapital?

SiteOne Therapeutics

South San Francisco, California, United States

SiteOne Therapeutics is a biopharmaceutical company that develops pain therapeutics to treat sensory disorders.

BiotechnologyHealth DiagnosticsMedicalTherapeutics
Series CDec 18, 2024
Amount Raised: $100,000,000
Alessa Therapeutics

San Francisco, California, United States

Alessa Therapeutics develops localized treatments for solid organ disease.

BiotechnologyHealth CareTherapeutics
SeedDec 12, 2024
Amount Raised: $15,000,000
Nuvig Therapeutics

Redwood City, California, United States

Nuvig Therapeutics is a biotechnology company developing therapies to induce natural mechanisms to restore immune homeostasis.

BiotechnologyHealth CareTherapeutics
Series BDec 5, 2024
Amount Raised: $161,000,000
Jupiter BioVentures

Delaware City, Delaware, United States

Jupiter BioVentures is a creation engine company that focuses on de-risking early-stage projects.

BiotechnologyTherapeutics
Series UnknownNov 19, 2024
Amount Raised: $70,000,000
Babylon Biosciences

San Francisco, California, United States

Babylon Biosciences is focused on discovering and developing small-molecule therapeutics to treat Alzheimer's disease.

Biotechnology
Pre SeedOct 30, 2024
Bullseye Biosciences

Allston, Massachusetts, United States

Bullseye Biosciences is a biotechnology company that offers drug discovery services.

Artificial Intelligence (AI)BiopharmaBiotechnology
Pre SeedOct 30, 2024
Cloverleaf Bio

New Haven, Connecticut, United States

Cloverleaf Bio develops an RNA therapeutic platform for oncology.

BiotechnologyGeneticsManufacturing
Pre SeedOct 30, 2024
NuCyRNA Therapeutics

Boston, Massachusetts, United States

NuCyRNA Therapeuticsis a RNA-targeting therapeutics based on a novel oligonucleotide platform, with an initial focus on CNS diseases.

Biotechnology
SeedOct 30, 2024
Velocity Bio

San Carlos, California, United States

Velocity Bio is a Stanford University spinout developing high-throughput platforms capable of selectivity-first allosteric drug discovery.

BiotechnologyLife ScienceProduct Research
SeedOct 30, 2024
Umlaut.Bio

Heidelberg, Baden-Wurttemberg, Germany

Umlaut.Bio is a spinout of the EMBL, is pursuing tRNA targets for treatment of cancer and immunological diseases.

SeedOct 30, 2024